Virginia bills · 2026 Regular Session
Virginia HB 712
Office-based buprenorphine treatment; Board of Medicine to amend regulations.
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- H. Otto Wachsmann, Jr. (Republican)
Summary
Official abstract published by the Virginia legislature· SUMMARY AS PASSED
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder. This bill is a recommendation of the Joint Commission on Health Care and is identical to SB 641.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 4:19 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Feb 23, 2026 Senate | Passage R | pass | Set your home in Virginia to see |
| Feb 20, 2026 Senate | Constitutional reading dispensed (on 2nd reading) | pass | Set your home in Virginia to see |
| Feb 19, 2026 Senate | Reported from Education and Health | pass | Set your home in Virginia to see |
| Feb 2, 2026 House | H VOTE: | pass | Set your home in Virginia to see |
| Jan 27, 2026 House | Reported from Health and Human Services | pass | Set your home in Virginia to see |
| Jan 22, 2026 House | Subcommittee recommends reporting | pass | Set your home in Virginia to see |
Actions
- Apr 6, 2026
Acts of Assembly Chapter text (CHAP0207) - Apr 6, 2026
Approved by Governor-Chapter 207 (effective 7/1/2026) - Mar 10, 2026
Governor's Action Deadline 11:59 p.m., April 13, 2026 - Mar 10, 2026 · House
Enrolled Bill communicated to Governor on March 10, 2026 - Feb 26, 2026 · House
Fiscal Impact Statement from Department of Planning and Budget (HB712) - Feb 25, 2026 · Senate
Signed by President - Feb 25, 2026 · House
Signed by Speaker - Feb 25, 2026 · House
Bill text as passed House and Senate (HB712ER) - Feb 25, 2026 · House
Enrolled - Feb 23, 2026 · Senate
Passed Senate (38-Y 0-N 0-A) - Feb 23, 2026 · Senate
Read third time - Feb 20, 2026 · Senate
Passed by for the day (Voice Vote) - Feb 20, 2026 · Senate
Constitutional reading dispensed (on 2nd reading) (40-Y 0-N 0-A) - Feb 20, 2026 · Senate
Rules suspended - Feb 19, 2026 · Senate
Reported from Education and Health (13-Y 0-N) - Feb 3, 2026 · Senate
Referred to Committee on Education and Health - Feb 3, 2026 · Senate
Constitutional reading dispensed (on 1st reading) - Feb 2, 2026 · House
Read third time and passed House (99-Y 0-N 0-A) - Jan 30, 2026 · House
Read second time and engrossed - Jan 29, 2026 · House
Read first time - Jan 27, 2026 · House
Reported from Health and Human Services (22-Y 0-N) - Jan 22, 2026 · House
Subcommittee recommends reporting (10-Y 0-N) - Jan 21, 2026 · House
Assigned sub: Health Professions - Jan 16, 2026 · House
Fiscal Impact Statement from Department of Planning and Budget (HB712) - Jan 13, 2026 · House
Referred to Committee on Health and Human Services - Jan 13, 2026 · House
Prefiled and ordered printed; Offered 01-14-2026 26104755D